Cited by 115Ovarian function and disordersEndometriosis Research and TreatmentReproductive Health and Contraception

Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis

Open access
Domecq, Juan Pablo, Prutsky, Gabriela, Mullan, Rebecca J., Sundaresh, Vishnu, Wang, Amy T., Erwin, Patricia J., Welt, Corrine, Ehrmann, David +2 more·2013·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is common among women of childbearing age and the available pharmacological therapies have different side-effect profiles. OBJECTIVE: We summarized the evidence about the side effects of oral contraceptive pills, metformin, and anti-androgens in women with PCOS. DATA SOURCE: Sources included Ovid Medline, OVID EMBASE, OVID Cochrane Library, Web of Science, Scopus, PsycInfo, and CINAHL from inception through April 2011. STUDY SELECTION: We included comparative observational studies enrolling women with PCOS who received the agents of choice for at least 6 months and reported adverse effects. DATA EXTRACTION: Using a standardized, piloted, and Web-based data extraction form and working in duplicate, we abstracted data from each study and performed meta-analysis when possible. DATA SYNTHESIS: We found 22 eligible studies of which 20 were randomized. No study reported severe side effects (eg, lactic acidosis, thromboembolic episodes, liver toxicity, cancer incidence, or pregnancy loss). Meta-analysis demonstrated no significant change in weight in oral contraceptive pills or flutamide users. Indirect evidence from populations without PCOS demonstrated no increased risk of lactic acidosis with metformin, only case reports of liver toxicity with flutamide (no comparative evidence), and increased relative risk difference of venous thromboembolism with oral contraceptive pills but very low absolute risk. Evidence on mortality, cardiovascular mortality, and cancer was inconclusive. CONCLUSIONS: Drugs commonly used to treat PCOS appear to be associated with very low risk of severe adverse effects although data are extrapolated from other populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2013-2374

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Domecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H.
Affiliations
  • Mayo Clinic (US)
  • University of Minnesota (US)
  • Massachusetts General Hospital (US)
  • University of Chicago (US)
Corresponding author
Murad, Mohammad Hassan
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-12
Volume
98
Issue
12
Pages
4646-4654
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1979724250
Cited by
115
References
71
Citations by year
2026: 14 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 2 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 8 · 2016: 11 · 2015: 10 · 2014: 8 · 2013: 2
FWCI
12.48
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065029)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
polycystic ovary syndrome, adverse drug reactions, oral contraceptives, metformin, androgen receptor antagonists, flutamide, lactic acidosis, venous thromboembolism, hepatotoxicity, weight change, cardiovascular mortality, cancer risk
MeSH terms
Androgen Antagonists, Contraceptives, Oral, Female, Flutamide, Humans, Hypoglycemic Agents, Metformin, Polycystic Ovary Syndrome, Risk Factors, Evidence-Based Medicine, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review